Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure

New England Journal of Medicine

Volumn 343, Issue 4, 2000, Pages 246-253

  Colucci, Wilson S ^a   Elkayam, Uri ^b   Horton, Darlene P ^c   Abraham, William T ^d   Bourge, Robert C ^e   Johnson, Allen D ^f   Wagoner, Lynne E ^d   Givertz, Michael M ^a   Liang, Chang Seng ^g   Neibaur, Matthew ^h   Haucht, W Herbert ⁱ   Lejemtel, Thierry H ^j  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Clinical Research Department   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^h Jacksonville Transplant Center   (United States)

ⁱ Jacksonville Center for Clinical Research   (United States)

^j ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HORMONAL THERAPY; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ATRIAL NATRIURETIC FACTOR; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DYSPNEA; FATIGUE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PULMONARY WEDGE PRESSURE; VASODILATOR AGENTS;

EID: 0034721244     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200007273430403     Document Type: Article

References (11)

1. Braunwald E, Colucci WS, Grossman W. Clinical aspects of heart failure. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine 5th ed. Vol. 1. Philadelphia: W.B. Saunders, 1997:445-70.
2. Stevenson LW, Colucci WS. Management of patients hospitalized with heart failure. In: Smith TW, ed. Cardiovascular therapeutics. Philadelphia: W.B. Saunders, 1996:199-209.
3. Wei CM, Heublein DM, Perrella MA, et al. Natriuretic peptide system in human heart failure. Circulation 1993;88:1004-9.
4. Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 1993;76:91-6.
5. Marcus LS, Hart D, Packer M, et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure: a double-blind, placebo-controlled, randomized cross-over trial. Circulation 1996;94:3184-9.
6. Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail 1998;4:37-44.
7. Mills RM, LeJemtel TH, Horton DP, et al. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 1999;34:155-62.
8. Colucci WS, Packer M, Bristow MR, et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation 1996;94:2800-6.
9. Tisdale JE, Patel R, Webb CR, Borzak S, Zarowitz BJ. Electrophysiologic and proarrhythmic effects of intravenous inotropic agents. Prog Cardiovasc Dis 1995;38:167-80.
10. Anderson JL, Askins JC, Gilbert EM, Menlovc RL, Lutz JR. Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone. Am Heart J 1986;111:466-74.
11. Packer M, Lee WH, Kessler PD, Gottlich SS, Medina N, Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 1987;317:799-804.